1,732
Views
85
CrossRef citations to date
0
Altmetric
Research Article

Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction

, , , , , , , , , , & show all
Pages 353-370 | Received 10 Dec 2009, Accepted 14 Dec 2009, Published online: 12 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Matteo Gastaldi, Silvia Scaranzin, Pietro Businaro, Emanuela Mobilia, Luana Benedetti, Giampaola Pesce & Diego Franciotta. (2021) Improving laboratory diagnostics in myasthenia gravis. Expert Review of Molecular Diagnostics 21:6, pages 579-590.
Read now
Trust Saidi, Sudesh Sivarasu & Tania S. Douglas. (2018) Open source modular ptosis crutch for the treatment of myasthenia gravis. Expert Review of Medical Devices 15:2, pages 137-143.
Read now
Amelia Evoli, Raffaele Iorio & Emanuela Bartoccioni. (2016) Overcoming challenges in the diagnosis and treatment of myasthenia gravis. Expert Review of Clinical Immunology 12:2, pages 157-168.
Read now
Matthew N Meriggioli & Donald B Sanders. (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis?. Expert Review of Clinical Immunology 8:5, pages 427-438.
Read now
Marc H. De Baets. (2010) Insights in the autoimmunity of myasthenia gravis. Autoimmunity 43:5-6, pages 341-343.
Read now
Kathleen Vrolix, Judith Fraussen, Peter C. Molenaar, Mario Losen, Veerle Somers, Piet Stinissen, Marc H. De Baets & Pilar Martínez-Martínez. (2010) The auto-antigen repertoire in myasthenia gravis. Autoimmunity 43:5-6, pages 380-400.
Read now

Articles from other publishers (79)

Rebecca Golfinopoulou, Véronique Giudicelli, Taciana Manso & Sofia Kossida. (2023) Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis. Vaccines 11:12, pages 1756.
Crossref
Naoko Suga, Yuka Ikeda, Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura & Satoru Matsuda. (2023) In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases. Neurology International 15:3, pages 967-979.
Crossref
Shuang Li, Hui Liu, Zhe Ruan, Rongjing Guo, Chao Sun, Yonglan Tang, Xiaoxi Huang, Ting Gao, Sijia Hao, Huanhuan Li, Na Song, Yue Su, Fan Ning, Zhuyi Li & Ting Chang. (2023) Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis. Journal of Translational Medicine 21:1.
Crossref
Mingli Zhao, Li Liu, Fanzhao Liu, Lei Liu, Zhijuan Liu, Yanli Gao & Jianxi Cao. (2023) Traditional Chinese medicine improves myasthenia gravis by regulating the symbiotic homeostasis of the intestinal microbiota and host. Frontiers in Microbiology 13.
Crossref
Ian Tizard. 2023. Autoimmune Diseases in Domestic Animals. Autoimmune Diseases in Domestic Animals 147 160 .
Senhui Weng, Jinghao Li, Benshu Chen, Long He, Zhuotai Zhong, Linwen Huang, Shijing Zhang, Fengbin Liu & Qilong Jiang. (2022) Effectiveness of modified Buzhong Yiqi decoction in treating myasthenia gravis: study protocol for a series of N-of-1 trials. Trials 23:1.
Crossref
Xiaoyu Huang, Jie Zhu, Tan Liu, Fengzhan Li, Tingting Yang, Hao Li, Fei Chen, Yong Zhang, Yuzhong Wang, Linlin Fu, Chenghua Xiao & Deqin Geng. (2021) Increased Expression of CD95 in CD4+ Effector Memory T Cells Promotes Th17 Response in Patients with Myasthenia Gravis. Journal of Neuroimmune Pharmacology 17:3-4, pages 437-452.
Crossref
Marina Mané-Damas, Peter C. Molenaar, Peter Ulrichts, Florit Marcuse, Marc H. De Baets, Pilar Martinez-Martinez & Mario Losen. (2022) Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders. Autoimmunity Reviews 21:7, pages 103104.
Crossref
Enze Xing, Allison C. Billi & Johann E. Gudjonsson. (2022) Sex Bias and Autoimmune Diseases. Journal of Investigative Dermatology 142:3, pages 857-866.
Crossref
Lukas Bankamp, Beate Preuß, Ann-Christin Pecher, Nicola Beucke, Jörg Henes & Reinhild Klein. (2021) Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA. Frontiers in Immunology 12.
Crossref
Soudeh Ghafouri-Fard, Tahereh Azimi, Bashdar Mahmud Hussen, Mohammad Taheri & Reza Jalili Khoshnoud. (2021) A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis. International Journal of Molecular Sciences 22:23, pages 12964.
Crossref
Michał K. Zarobkiewicz, Izabela Morawska, Adam Michalski, Jacek Roliński & Agnieszka Bojarska-Junak. (2021) NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases—Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome. International Journal of Molecular Sciences 22:17, pages 9520.
Crossref
Christian Mayer, Beate Preuss, Julia Grottenthaler, Christoph Berg & Reinhild Klein. (2020) Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes. Frontiers in Immunology 11.
Crossref
Konstantinos Lazaridis & Socrates J. Tzartos. (2020) Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. Frontiers in Immunology 11.
Crossref
Salvatore R. Guarino, Anselmo Canciani & Federico Forneris. (2020) Dissecting the Extracellular Complexity of Neuromuscular Junction Organizers. Frontiers in Molecular Biosciences 6.
Crossref
Florencia Aguirre, Analisa Manin, Victoria C. Fernandez, Mariano E. Justo, Juliana Leoni, Mariela L. Paz & Andres M. Villa. (2020) C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis. Therapeutic Advances in Neurological Disorders 13, pages 175628642093569.
Crossref
Marina Mané-Damas, Carolin Hoffmann, Shenghua Zong, Amanda Tan, Peter C. Molenaar, Mario Losen & Pilar Martinez-Martinez. (2019) Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities. Autoimmunity Reviews 18:9, pages 102348.
Crossref
Jie Song, Jian-Ying Xi, Wen-Bo Yu, Chong Yan, Su-Shan Luo, Lei Zhou, Wen-Hua Zhu, Jia-Hong Lu, Qiang Dong, Bao-Guo Xiao & Chong-Bo Zhao. (2019) Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis. Clinical Immunology 203, pages 142-153.
Crossref
Mariela L. Paz & Francisco J. Barrantes. (2019) Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets. ACS Chemical Neuroscience 10:5, pages 2186-2194.
Crossref
Ryuichi Nakamura, Tomohiro Makino, Takeshi Hanada, Maki Terakawa, Kazuhiro Nagahira, Jyoji Yamate, Hirokazu Shiraishi & Masakatsu Motomura. (2018) Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 320, pages 64-75.
Crossref
David C. Trampert, Lowiek M. Hubers, Stan F.J. van de Graaf & Ulrich Beuers. (2018) On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:4, pages 1401-1409.
Crossref
Konstantinos Lazaridis, Ioannis Dalianoudis, Vasiliki Baltatzidi & Socrates J. Tzartos. (2017) Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 312, pages 24-30.
Crossref
Abhishek Saxena, Jo Stevens, Hakan Cetin, Inga Koneczny, Richard Webster, Konstantinos Lazaridis, Socrates Tzartos, Kathleen Vrolix, Gisela Nogales-Gadea, Barbie Machiels, Peter C. Molenaar, Jan Damoiseaux, Marc H. De Baets, Katja Simon-Keller, Alexander Marx, Angela Vincent, Mario Losen & Pilar Martinez-Martinez. (2017) Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient. Scientific Reports 7:1.
Crossref
Hai-Feng Li, Yu Hong, Xu Zhang, Yanchen Xie, Geir Olve Skeie, Hong-Jun Hao, Nils Erik Gilhus, Bing Liang, Yao-Xian Yue, Xian-Jun Zhang, Xiang Gao, Qi Wang, Zhe Gao, Xiao-Jun Ding & Min Song. (2016) Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis. Molecular Neurobiology 54:6, pages 4771-4780.
Crossref
Shenghua Zong, Carolin Hoffmann, Marina Mané-Damas, Peter Molenaar, Mario Losen & Pilar Martinez-Martinez. (2017) Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?. Frontiers in Immunology 8.
Crossref
Kaori Noridomi, Go Watanabe, Melissa N Hansen, Gye Won Han & Lin Chen. (2017) Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications. eLife 6.
Crossref
Konstantinos Lazaridis, Vassiliki Baltatzidi, Nikolaos Trakas, Eleni Koutroumpi, Nikolaos Karandreas & Socrates J. Tzartos. (2017) Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains. Journal of Neuroimmunology 303, pages 13-21.
Crossref
Frédérique Truffault, Vincent de Montpreville, Bruno Eymard, Tarek Sharshar, Rozen Le Panse & Sonia Berrih-Aknin. (2016) Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review. Clinical Reviews in Allergy & Immunology 52:1, pages 108-124.
Crossref
Jacob I. Meyers & Brian D. Foy. 2017. Arthropod Vector: Controller of Disease Transmission, Volume 1. Arthropod Vector: Controller of Disease Transmission, Volume 1 143 160 .
Alejandro M. Gomez, Jo A.A. Stevens, Marina Mané-Damas, Peter Molenaar, Hans Duimel, Fons Verheyen, Judith Cossins, David Beeson, Marc H. De Baets, Mario Losen & Pilar Martinez-Martinez. (2016) Silencing of Dok-7 in Adult Rat Muscle Increases Susceptibility to Passive Transfer Myasthenia Gravis. The American Journal of Pathology 186:10, pages 2559-2568.
Crossref
Andreas Goebel. (2016) Autoantibody pain. Autoimmunity Reviews 15:6, pages 552-557.
Crossref
Carolin Hoffmann, Shenghua Zong, Marina Mané-Damas, Peter Molenaar, Mario Losen & Pilar Martinez-Martinez. (2016) Autoantibodies in Neuropsychiatric Disorders. Antibodies 5:2, pages 9.
Crossref
William D. Phillips & Angela Vincent. (2016) Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms. F1000Research 5, pages 1513.
Crossref
Inga Koneczny, Pilar Martinez Martinez & Marc De Baets. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 168 179 .
Jeffrey T. Guptill, Madhu Soni & Matthew N. Meriggioli. (2015) Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis. Neurotherapeutics 13:1, pages 118-131.
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2016. Diseases in the Elderly. Diseases in the Elderly 151 213 .
Marie Maurer, Sylvain Bougoin, Tali Feferman, Mélinée Frenkian, Jacky Bismuth, Vincent Mouly, Geraldine Clairac, Socrates Tzartos, Elie Fadel, Bruno Eymard, Sara Fuchs, Miriam C Souroujon & Sonia Berrih-Aknin. (2015) IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis. Acta Neuropathologica Communications 3:1.
Crossref
Jie Luo & Jon Lindstrom. (2015) AChR-specific immunosuppressive therapy of myasthenia gravis. Biochemical Pharmacology 97:4, pages 609-619.
Crossref
M. Demestre, M. Orth, K.J. Föhr, K. Achberger, A.C. Ludolph, S. Liebau & T.M. Boeckers. (2015) Formation and characterisation of neuromuscular junctions between hiPSC derived motoneurons and myotubes. Stem Cell Research 15:2, pages 328-336.
Crossref
Jennie Lönnbro-Widgren, Kerstin Ebefors, Johan Mölne, Jenny Nyström & Börje Haraldsson. (2015) Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy. Clinical Kidney Journal 8:4, pages 433-439.
Crossref
Mario Losen, Pilar Martinez-Martinez, Peter C. Molenaar, Konstantinos Lazaridis, Socrates Tzartos, Talma Brenner, Rui-Sheng Duan, Jie Luo, Jon Lindstrom & Linda Kusner. (2015) Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors ? Recommendations for methods and experimental designs. Experimental Neurology 270, pages 18-28.
Crossref
W.D. Phillips, P. Christadoss, M. Losen, A.R. Punga, K. Shigemoto, J. Verschuuren & A. Vincent. (2015) Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis. Experimental Neurology 270, pages 29-40.
Crossref
K. Lazaridis, P. Evaggelakou, E. Bentenidi, A. Sideri, E. Grapsa & S.J. Tzartos. (2015) Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains. Journal of Neuroimmunology 278, pages 19-25.
Crossref
Linda L. Kusner & Henry J. Kaminski. 2015. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders 135 150 .
Yan Li, Zhidan Tu, Shiguang Qian, John J. Fung, Sanford D. Markowitz, Linda L. Kusner, Henry J. Kaminski, Lina Lu & Feng Lin. (2014) Myeloid-Derived Suppressor Cells as a Potential Therapy for Experimental Autoimmune Myasthenia Gravis. The Journal of Immunology 193:5, pages 2127-2134.
Crossref
Muthusamy Thiruppathi, Jian Rong Sheng, Liangcheng Li, Bellur S. Prabhakar & Matthew N. Meriggioli. (2014) Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis. Journal of Autoimmunity 52, pages 64-73.
Crossref
Ozgur Duman, Resit Koken, R. Taner Baran, Senay Haspolat & Haluk Topaloglu. (2014) Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3. European Journal of Paediatric Neurology 18:4, pages 526-528.
Crossref
B Preuss, S Tunaru, J Henes, S Offermanns & R Klein. (2014) A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera. Clinical and Experimental Immunology 177:1, pages 179-189.
Crossref
J. B. Andersen, A. T. Heldal, A. Engeland & N. E. Gilhus. (2014) Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurologica Scandinavica 129, pages 26-31.
Crossref
J P Sieb. (2014) Myasthenia gravis: an update for the clinician. Clinical and Experimental Immunology 175:3, pages 408-418.
Crossref
Yu Hong, Hong-Jun Hao, Yan-Chen Xie, Qi Wang & Hai-Feng Li. (2014) Effect of storage conditions and freeze/thaw cycles on serum and plasma levels of anti-acetylcholine receptor (AChR) antibody. Clinical Chemistry and Laboratory Medicine (CCLM) 52:6.
Crossref
Inga Koneczny, Judith Cossins & Angela Vincent. (2014) The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. Journal of Anatomy 224:1, pages 29-35.
Crossref
H. Peng, Y. Yang & M.K. Racke. 2014. Encyclopedia of the Neurological Sciences. Encyclopedia of the Neurological Sciences 669 674 .
Blanka Kellermayer, Noemi Polgar, Jozsef Pal, Miklos Banati, Anita Maasz, Peter Kisfali, Zsolt Hosszu, Annamaria Juhasz, Henrik Boye Jensen, Attila Tordai, Csilla Rozsa, Bela Melegh & Zsolt Illes. (2013) Association of myasthenia gravis with polymorphisms in the gene of histamine N-methyltransferase. Human Immunology 74:12, pages 1701-1704.
Crossref
Constanza B. Kamerbeek, Virginia Borroni, María F. Pediconi, Satoshi B. Sato, Toshihide Kobayashi & Francisco J. Barrantes. (2013) Antibody-Induced Acetylcholine Receptor Clusters Inhabit Liquid-Ordered and Liquid-Disordered Domains. Biophysical Journal 105:7, pages 1601-1611.
Crossref
Alejandro M. Gomez, Annelies Vanheel, Mario Losen, Peter C. Molenaar, Marc H. De Baets, Jean-Paul Noben, Niels Hellings & Pilar Martinez-Martinez. (2013) Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 261:1-2, pages 141-145.
Crossref
Amelia Evoli & Luca Padua. (2013) Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase. Autoimmunity Reviews 12:9, pages 931-935.
Crossref
Jan J.G.M. Verschuuren, Maartje G. Huijbers, Jaap J. Plomp, Erik H. Niks, Peter C. Molenaar, Pilar Martinez-Martinez, Alejandro M. Gomez, Marc H. De Baets & Mario Losen. (2013) Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmunity Reviews 12:9, pages 918-923.
Crossref
김지영 & 박기덕. (2013) Immunopathologic Change of Neuromuscular Junction in Myasthenia Gravis. Jouranl of Korean Association of EMG Electrodiagnostic Medicine 15:1, pages 6-10.
Crossref
Puay-Wah Phuan, Hua Zhang, Nithi Asavapanumas, Michael Leviten, Arnon Rosenthal, Lukmanee Tradtrantip & A. S. Verkman. (2013) C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathologica 125:6, pages 829-840.
Crossref
Marco Morsch, Stephen W. Reddel, Nazanin Ghazanfari, Klaus V. Toyka & William D. Phillips. (2013) Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. The Journal of Physiology 591:10, pages 2747-2762.
Crossref
Zoi Zagoriti, Manousos E. Kambouris, George P. Patrinos, Socrates J. Tzartos & Konstantinos Poulas. (2013) Recent Advances in Genetic Predisposition of Myasthenia Gravis. BioMed Research International 2013, pages 1-12.
Crossref
Corey R. Fehnel, Ala Nozari & Lee H. Schwamm. 2013. Critical Care Secrets. Critical Care Secrets 452 455 .
Linda L. Kusner, Jose A. Halperin & Henry J. Kaminski. (2012) Cell surface complement regulators moderate experimental myasthenia gravis pathology. Muscle & Nerve 47:1, pages 33-40.
Crossref
Chang-Suk Chae, Ho-Keun Kwon, Ji-Sun Hwang, Jung-Eun Kim & Sin-Hyeog Im. (2012) Prophylactic Effect of Probiotics on the Development of Experimental Autoimmune Myasthenia Gravis. PLoS ONE 7:12, pages e52119.
Crossref
Chunmei Wang, Yonghai Lu, Zhixi Chen, Xiaobin Liu, Huangquan Lin, Hui Zhao, Jinyan Chen, Yiuwa Kwan & Saiming Ngai. (2012) Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang. Chinese Medicine 7:1.
Crossref
Alejandro M. Gomez, Nick Willcox, Peter C. Molenaar, Wim Buurman, Pilar Martinez-Martinez, Marc H. De Baets & Mario Losen. (2012) Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?. Annals of the New York Academy of Sciences 1274:1, pages 48-59.
Crossref
Konstantinos Lazaridis, Paraskevi Zisimopoulou, George Lagoumintzis, Labrini Skriapa, Nikos Trakas, Panagiota Evangelakou, Ioannis Kanelopoulos, Eirini Grapsa, Kostas Poulas & Socrates Tzartos. (2012) Antigen-specific apheresis of autoantibodies in myasthenia gravis. Annals of the New York Academy of Sciences 1275:1, pages 7-12.
Crossref
J. Calvino, M. Adeva & M.-J. Sobrido. (2012) Membranous nephropathy, leiomyoma and autoimmune myasthenia: more than a coincidence?. Clinical Kidney Journal 5:6, pages 562-565.
Crossref
Puay-Wah Phuan, Julien Ratelade, Andrea Rossi, Lukmanee Tradtrantip & A.S. Verkman. (2012) Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays. Journal of Biological Chemistry 287:17, pages 13829-13839.
Crossref
Jindrich Soltys, Jose A. Halperin & Qin Xuebin. (2012) DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 244:1-2, pages 63-69.
Crossref
Fulvio Baggi, Carlo Antozzi, Chiara Toscani & Chiara Cordiglieri. (2011) Acetylcholine Receptor-Induced Experimental Myasthenia Gravis: What Have We Learned from Animal Models After Three Decades?. Archivum Immunologiae et Therapiae Experimentalis 60:1, pages 19-30.
Crossref
Roy G Beran. 2012. Neurology for general practitioners. Neurology for general practitioners 171 186 .
Cosmin A. Tegla, Cornelia Cudrici, Snehal Patel, Richard TrippeIIIIII, Violeta Rus, Florin Niculescu & Horea Rus. (2011) Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunologic Research 51:1.
Crossref
Roxanna Khorzad, Megan Whelan, Allen Sisson & G. D. Shelton. (2011) Myasthenia gravis in dogs with an emphasis on treatment and critical care management. Journal of Veterinary Emergency and Critical Care 21:3, pages 193-208.
Crossref
Miwa Uzuki, Akihisa Kamataki, Mika Watanabe, Nobuhito Sasaki, Yasuhiro Miura & Takashi Sawai. (2011) Histological analysis of esophageal muscular layers from 27 autopsy cases with mixed connective tissue disease (MCTD). Pathology - Research and Practice 207:6, pages 383-390.
Crossref
Shahar Shelly, Nancy Agmon-Levin, Arie Altman & Yehuda Shoenfeld. (2011) Thymoma and autoimmunity. Cellular & Molecular Immunology 8:3, pages 199-202.
Crossref
Alejandro M. Gomez, Kathleen Vrolix, Pilar Martínez-Martínez, Peter C. Molenaar, Marko Phernambucq, Eline van der Esch, Hans Duimel, Fons Verheyen, Reinhard E. Voll, Rudolf A. Manz, Marc H. De Baets & Mario Losen. (2011) Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis. The Journal of Immunology 186:4, pages 2503-2513.
Crossref
Jozsef Pal, Csilla Rozsa, Samuel Komoly & Zsolt Illes. (2011) Clinical and biological heterogeneity of autoimmune myasthenia gravis. Journal of Neuroimmunology 231:1-2, pages 43-54.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.